✦ LIBER ✦

Botulinum toxin

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 826 KB
Volume: 7
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870070555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to botulinum toxin F in seroneg

Response to botulinum toxin F in seronegative botulinum toxin A—resistant patients

✍ Dr. Paul E. Greene; Stanley Fahn 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

## Abstract Botulinum toxin type A (btx A) injections are the most effective treatment for most patients with focal dystonia. Some patients who improve after btx A injections and later lose response have serologic evidence of antibodies to btx A with the mouse neutralization assay (seropositive pat

Botulinum toxin antibody type A titres a

Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy

✍ Dirk Dressler; Hans Bigalke 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract In some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight

How does botulinum toxin work?

✍ Mark Hallett 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

Botulinum toxin: Problems and perspectiv

Botulinum toxin: Problems and perspectives

✍ A. O. Ceballos-Baumann 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Botulinum toxins in neurological disease

✍ Cynthia L. Comella; Seth L. Pullman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Treatment of spasticity with botulinum t

Treatment of spasticity with botulinum toxin

✍ David M. Simpson 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Restoration of neurological function following injury to the nervous system has long been the aim of neuroscientists and clinicians. The central nervous system (CNS) has proven to be an elusive target for restorative treatment. Although neuroprotective agents show promise, once injury to the brain o